A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Clinical trial NCT05981703 · RECRUITING

Trial details

NCT number: NCT05981703
Sponsor: BeOne Medicines
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Solid Tumor

Start date: 2023-09-21
Primary completion: 2027-09-30
Enrollment: 217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.